Tenax Therapeutics Inc
Biotechnology
Healthcare
TENX
21.00 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
5.60
52 week high
7.52
high
5.77
52 week low
2.77
low
5.30
growth
59.83 %
previous Close
5.83
P/E ratio
market cap
21.48 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-3.96 M
-10.76 %
eps
0.00 %
89.62 %
eps surprise
86.33 %
net profit margin
-396046900.00 %
0.00 %
operating incoming
4.62 M
225.79 %
net change in cash
88.93 M
2.00 %
cash on hand
98.31 M
947.64 %
cost of revenue
0.00 %
top top